openPR Logo
Press release

Ketamine treatment Market Increasing Demand, Growth Analysis and Future Outlook by 2031

04-04-2024 02:11 PM CET | Health & Medicine

Press release from: Orion Market Research

Ketamine treatment Market Increasing Demand, Growth Analysis

The global ketamine treatment market is anticipated to grow at a significant CAGR of 43.7% during the forecast period (2024-2031). The market growth is primarily driven by the prevalence of treatment-resistant depression. Additionally, the development of innovative formulations and delivery methods to enhance safety and efficacy is also contributing to the market growth. Furthermore, the increasing awareness about the potential benefits of Ketamine and its efficacy properties for mental health conditions is also fuelling the market growth.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/ketamine-treatment-market

The World Health Organisation (WHO) estimated that 3.8% of the population experienced depression. This included 5.0% of adults (4.0% among men and 6.0% among women), and 5.7% of adults older than 60 years. Approximately 280 million people in the world have depression. Depression is about 50.0% more common among women than among men. Additionally, more than 10.0% of pregnant women and women who have just given birth experience depression. It has also been found that suicide is the fourth major cause of fatalities (majorly in 15-29-year-olds) accounting for 700,000 casualties every year. Additionally, more than 75.0% of people in low- and middle-income countries receive no treatment for mental disorders.

The global ketamine treatment market is segmented based on route of administration (into oral, infusions, and nasal spray), application (into treatment-resistant depression (TRD), anxiety disorder, post-traumatic stress disorder (PTSD), and others), end-user (into hospitals and medical centers, specialized ketamine clinics, psychiatric hospitals, and others) and geographies (into North America, Europe, Asia-Pacific, and the Rest of the World).

A full report of Ketamine treatment Market available @ https://www.omrglobal.com/industry-reports/ketamine-treatment-market

Market Highlights and Restraints

• The infusions segment is expected to capture a significant market share attributed to the increasing incidence of depression and mood disorders and the growing number of specialized Ketamine clinics.

• Additionally, the nasal spray segment is expected to hold a considerable market share owing to the growing diversification of treatment options. For instance, the introduction of novel medicines, such as SPRAVATO, is expanding the number of alternatives available to individuals.

• In June 2022, Ketamine Wellness Centers (KWC), expanded the availability of SPRAVATO to three new cities and increased the total number of clinics offering the FDA-approved ketamine nasal spray to six.

• Europe is anticipated to hold a prominent market share owing to the development of Ketamine clinics.

• Additionally, the North American region is anticipated to grow at a considerable CAGR over the forecast period attributing to the rising Posttraumatic Stress Disorder (PTSD) prevalence, especially in military veterans and first responders across the region.

• The National Institute of Health, in March 2023, reported a lifetime prevalence of PTSD in the general population is 3.9%, and 5.9% among those who have experienced trauma, with variations based on country and income level.

• Additionally, 78.5% of people with PTSD also meet the criteria for at least one other mental illness, most commonly Major Depressive Disorder (MDD). People with PTSD are also 2-4 times more likely to have depressive and anxiety disorders, as well as alcohol and substance abuse.

• However, the market growth is challenged by the potential side effects of ketamine consumption such as dissociation, nausea, vomiting, and dizziness. At times leyamine consumption could also have serious side effects such as high blood pressure, increased heart rate, and seizures.

The major players in the global ketamine treatment market include Core One Labs Inc., Enso Discoveries, LLC., Johnson & Johnson Pvt. Ltd., Ketamine Research Institute, Ketamine Wellness Centers, and others. The market players are considerably contributing to the market growth by the adoption of various business strategies. For instance, in November 2021, Seelos Therapeutics Acquired an Exclusive License of iX Biopharma for Wafermine a sublingual racemic ketamine wafer, in addition to a global license for other sublingual ketamine wafers, delivered via WaferiX, a proprietary fast-dissolving wafer-based drug delivery platform technology.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Visit more report at

https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/

https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ketamine treatment Market Increasing Demand, Growth Analysis and Future Outlook by 2031 here

News-ID: 3452285 • Views:

More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sustainability Preferences
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become
Railway Management System Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033. Railway Management System Market Overview The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033. Monocalcium Phosphate Market Overview Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033. Automotive Lubricants Market Overview The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by

All 5 Releases


More Releases for Ketamine

Helloinnerwell Unveils the Transformative Benefits of Ketamine for Mental Health …
Depression and anxiety remain major barriersto fulfillment for millions around the world. Traditional antidepressants may take weeks to months to have an effect, and many experience disastrous results, no results, or side effectsthat we do not want. But a new, scientifically backed treatmentnow exists that can bring you jarred relief, potentially fast and it uses a very interesting, and run-of-the-mill drug online therapy [https://helloinnerwell.com/] of ketamine. Compared to traditional medications, ketamine provides
Breakthroughs in Mental Health: Calliope Health Ketamine Expands Access to Ketam …
In recent years, the landscape of mental health treatment has seen remarkable advancements, with innovative therapies offering new hope to those battling conditions like depression, anxiety, and PTSD. Among these breakthroughs, ketamine therapy has emerged as a powerful option, providing rapid relief for individuals who have not responded to traditional treatments. Calliope Health Ketamine is at the forefront of this movement, expanding access to ketamine therapy in Maryland, where it
Ketamine treatment Market Share, Trends, Growth, Analysis and Forecast 2023-2030
The global ketamine treatment market is anticipated to grow at a CAGR of 43.7% during the forecast period (2023-2030). Ketamine has been widely used in the treatment of various conditions, including major depressive disorder, treatment-resistant depression (TRD), bipolar depression, post-traumatic stress disorder, anxiety disorders, chronic pain management, and migraine or headache management. Ketamine is also been used in the form of infusion therapy and nasal spray, and has been found
Ketamine treatment Market 2023 Driving Factors Forecast Research 2029
Ketamine treatment market is anticipated to grow at a CAGR of 43.74% during the forecast period (2023-2030). The market's growth is attributed to prevalence of treatment-resistant depression. A considerable number of individuals with MDD do not respond to standard therapies, resulting in a patient group known as TRD. This population has a significant unmet medical need. Ketamine's ability to bring relief to TRD sufferers has resulted in its increased use
Ketamine treatment Market 2023 Driving Factors Forecast Research 2029
Ketamine treatment market is anticipated to grow at a CAGR of 43.74% during the forecast period (2023-2030). The market's growth is attributed to prevalence of treatment-resistant depression. A considerable number of individuals with MDD do not respond to standard therapies, resulting in a patient group known as TRD. This population has a significant unmet medical need. Ketamine's ability to bring relief to TRD sufferers has resulted in its increased use
Ketamine Treatment Market to Witness Astonishing Growth by 2029
The global ketamine treatment market is anticipated to grow at a CAGR of 43.7% during the forecast period (2023-2030). Ketamine has been widely used in the treatment of various conditions, including major depressive disorder, treatment-resistant depression (TRD), bipolar depression, post-traumatic stress disorder, anxiety disorders, chronic pain management, and migraine or headache management. Ketamine is also been used in the form of infusion therapy and nasal spray, and has been found